Euros for Doctors

Since 2016, the 54 biggest pharma companies in Germany have published their payments to doctors and other health care professionals and organisations from the previous year.

Read the article

Only around a quarter of doctors and health care professionals agreed to the publication of their fees and conference and travel expenses.

Detailed payments to doctors related to studies and non-interventional studies are not published by the pharma companies.

Astrid Wever agreed to the publication of these payments:

Company Payment type
Total €64.00 €913.20
AstraZeneca GmbH fees
to: Praxis Dr. Wever
€750.00
UCB Innere Medizin GmbH & Co. KG fees €150.00
AstraZeneca GmbH related expenses
to: Praxis Dr. Wever
€13.20
UCB Pharma GmbH/ UCB GmbH travel & accommodation €64.00

The information on this page come from the 54 member companies of “Voluntary Self-Regulation of the pharmaceutical industry” (“Freiwilligen Selbstkontrolle für die Arzneimittelindustrie e.V.”) who published these payments on their websites.

Continue searching

More doctors and organisations nearby

Anne Winkelmann Suermondtstr. 13 €1,058.40
Elke Parsi Suermondtstr. 13 €3,210.80
Thomas Müller Gartenstr. 1 €15,381.51
Michael Baake Gartenstraße €3,522.63
Hajo Noll Berliner Allee 158 €2,164.10
More recipient near this address

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.